Developments in small animal veterinary dermatology.

about

Developments in small animal veterinary dermatology.

Item

http://www.wikidata.org/entity/Q50185658

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Developments in small animal veterinary dermatology.

@en

Developments in small animal veterinary dermatology.

@nl

type

Item

label

Developments in small animal veterinary dermatology.

@en

Developments in small animal veterinary dermatology.

@nl

prefLabel

Developments in small animal veterinary dermatology.

@en

Developments in small animal veterinary dermatology.

@nl

P1476

Developments in small animal veterinary dermatology.

@en

P2093

Kinga Gortel

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs

Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis

Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei

Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification

A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.

Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA).

Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs

Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.

Ciclosporin 10 years on: indications and efficacy.

P304

85-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29302108

http://www.w3.org/2001/XMLSchema#string

P932

5731399

http://www.w3.org/2001/XMLSchema#string